Copper Balance in Healthy Participants Administered ALXN1840

Trial Identifier:	ALXN1840-HV-108
Sponsor:	Alexion Pharmaceuticals
Start Date:	July 2020
Primary Completion Date:	November 2020
Study Completion Date:	November 2020
Condition:	Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description

	English (UK)

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United Kingdom	London, United Kingdom

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.